FDA
approval
· 2017-08-15
FDA Approved: PYRIDOSTIGMINE BROMIDE — Original Application (Rising Pharma Holdings, Inc.)
Summary
FDA approves a generic pyridostigmine bromide product under an Original Application (ANDA205464). The indication is treatment of myasthenia gravis, with Rising …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for PYRIDOSTIGMINE BROMIDE (PYRIDOSTIGMINE BROMIDE)